# Junta clínica — PT-pseudo_b6db06db35d7 (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_b6db06db35d7",
  "pid": "PT-pseudo_b6db06db35d7",
  "task": 1,
  "psa": 5.2,
  "age": 57,
  "months": 1,
  "pirads": "5",
  "psad": 0.11,
  "psav": 1.38,
  "psap": 3.2,
  "vol": 47.0,
  "dre": "Normal",
  "bx": "Positive",
  "cspca": 0.8199149,
  "medhx": "Osteoarthritis, Benign prostatic hyperplasia",
  "meds": "tamsulosin",
  "notes": "PSA 5.2 ng/mL. PI-RADS 5. PSAD 0.11. Prostate volume 47 mL. csPCa 0.82.",
  "pmhx": [
    "Osteoarthritis",
    "Benign prostatic hyperplasia"
  ],
  "allergies": [],
  "vitals": {
    "weight": "79 kg",
    "height": "182 cm",
    "bmi": "23.8",
    "bp": "119/89 mmHg",
    "hr": "73 bpm",
    "smoking": "Non-smoker",
    "last_dental": "6 mo ago",
    "flu_vax": "Oct 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "13 Jan 2025",
  "enc_ref": "Dr. E. Mulder (GP)",
  "enc_type": "Re-evaluation - prior PCa diagnosis",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Assessment of a recent PSA climb to 5.2 ng/mL alongside a newly identified PI-RADS 5 MRI finding and a previously Positive prior biopsy result."
    },
    {
      "s": "History",
      "t": "A 57-year-old non-smoker who lives independently, this widowed semi-retired musician carries a background of benign prostatic hyperplasia currently treated with tamsulosin. His initial urological workup began in early 2023 when a PSA reading of 2.3 ng/mL was noted, ultimately yielding a Positive prior biopsy. He experiences moderate lower urinary tract complaints, characterized by nocturia occurring twice each night and a diminished stream, yielding an IPSS of 11. Past medical history includes knee osteoarthritis and stable chronic obstructive pulmonary disease, the latter prompting a pulmonary function assessment earlier this month. He walks 45 minutes daily, limits alcohol to roughly 10 units per week, and enjoyed a stable cardiology check in autumn 2024. He explicitly denies bone discomfort, haematuria, or unaccounted weight reduction, citing only the 60-minute train journey to the clinic as a notable daily logistical hurdle."
    },
    {
      "s": "Physical examination",
      "t": "Per rectum: DRE confirms a normal examination with a symmetrically enlarged prostate, smooth and firm consistency, and absent nodules or asymmetry. General assessment shows stable vitals (BP 119/89 mmHg, HR 73 bpm) with no abdominal masses or lymphadenopathy. Nutritional status appears adequate, and independent ambulation is noted, accompanied by a mild antalgic gait attributable to established osteoarthritis."
    }
  ],
  "occupation": "musician (semi-retired)",
  "marital": "Widowed",
  "living": "Lives alone",
  "next_of_kin": "Adult daughter (primary contact)",
  "recent_other": [
    "Pulmonary function test — known COPD follow-up",
    "Cardiology — annual review (stable, autumn 2024)"
  ],
  "alcohol": "10 units / week",
  "exercise": "Walking 45 min/day",
  "ipss": "IPSS score: 11/35 (moderate LUTS)",
  "admin": "Patient travels 60+ min by train to clinic; allow buffer.",
  "mri_hospital": "Spaarne Gasthuis (Haarlem)",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_b6db06db35d7
Task: 1

Encounter: Urology - outpatient on 13 Jan 2025.
Referrer: Dr. E. Mulder (GP).
Type: Re-evaluation - prior PCa diagnosis.

Clinical data (read-only — values loaded from the record):
  - 57-year-old male
  - PSA: 5.2 ng/mL
  - mpMRI — PI-RADS score: 5 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.11 ng/mL²
  - PSA velocity: 1.38 ng/mL/yr
  - Prior PSA: 3.2 ng/mL
  - Prostate volume: 47.0 mL
  - Months since last PSA: 1
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: Positive (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.8199149 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Osteoarthritis, Benign prostatic hyperplasia
  - Problem list / PMHx: Osteoarthritis, Benign prostatic hyperplasia
  - Current medication: tamsulosin
  - Allergies: NKA
  - Additional notes: PSA 5.2 ng/mL. PI-RADS 5. PSAD 0.11. Prostate volume 47 mL. csPCa 0.82.

Vitals: weight 79 kg, height 182 cm, BMI 23.8, BP 119/89 mmHg, HR 73 bpm. Smoking: Non-smoker.

Chief complaint: Assessment of a recent PSA climb to 5.2 ng/mL alongside a newly identified PI-RADS 5 MRI finding and a previously Positive prior biopsy result.

History: A 57-year-old non-smoker who lives independently, this widowed semi-retired musician carries a background of benign prostatic hyperplasia currently treated with tamsulosin. His initial urological workup began in early 2023 when a PSA reading of 2.3 ng/mL was noted, ultimately yielding a Positive prior biopsy. He experiences moderate lower urinary tract complaints, characterized by nocturia occurring twice each night and a diminished stream, yielding an IPSS of 11. Past medical history includes knee osteoarthritis and stable chronic obstructive pulmonary disease, the latter prompting a pulmonary function assessment earlier this month. He walks 45 minutes daily, limits alcohol to roughly 10 units per week, and enjoyed a stable cardiology check in autumn 2024. He explicitly denies bone discomfort, haematuria, or unaccounted weight reduction, citing only the 60-minute train journey to the clinic as a notable daily logistical hurdle.

Physical examination: Per rectum: DRE confirms a normal examination with a symmetrically enlarged prostate, smooth and firm consistency, and absent nodules or asymmetry. General assessment shows stable vitals (BP 119/89 mmHg, HR 73 bpm) with no abdominal masses or lymphadenopathy. Nutritional status appears adequate, and independent ambulation is noted, accompanied by a mild antalgic gait attributable to established osteoarthritis.

Patient info: musician (semi-retired); Widowed; Lives alone.
Next of kin: Adult daughter (primary contact).

Lifestyle: alcohol 10 units / week; exercise Walking 45 min/day; IPSS score: 11/35 (moderate LUTS).

Recent other appointments: Pulmonary function test — known COPD follow-up; Cardiology — annual review (stable, autumn 2024).
Admin: Patient travels 60+ min by train to clinic; allow buffer.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.57
  uncertainty  +/- 0.10 epistemic (95% band 0.36-0.77); among patients I cannot tell apart the outcome was 0.99 of 1.00 mixed
  reliability  LOW ('discuss' tier) — out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = 2 on the problem list (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 57 (2% of my signal; from age) · DRE = Normal (10% of my signal; from dre_suspicious) · PSA = 5.2 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 47 mL (1% of my signal; from log_vol, vol) · PSA density = 0.11 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.82 (1% of my signal; from cspca) · PI-RADS = 5 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: uncertain — 'discuss' tier; out-of-fold it was right 55% of the time over the 38 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: prior positive biopsy. The panel alone does not answer, and that is the finding.

The criterion here is that the visible panel does not determine this decision: he already has a tissue diagnosis, so neither a high PI-RADS nor a rising PSA is new information. What decides it is the documented grade of the prior biopsy and the surveillance history, which live in the previous notes. Measured on the labelled series: none of the three panel
rules I carry for this situation (PSA >= 20, age >= 78, PI-RADS <= 2) applies to him, and among the
39 remaining labelled men in this situation no structured variable separates the two answers.

REGISTRAR: the previous notes are where this case is decided. Read them for the grade of the prior
biopsy (Gleason or ISUP), the number of biopsy sessions and their dates, and whether he is on a
surveillance protocol with a confirmatory biopsy due. Do not read this as 'defer' and do not read it
as 'biopsy'.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  important  prior biopsy = Positive
  noted      age = 57 · DRE = Normal · PSA = 5.2 ng/mL · prostate volume = 47 mL · PSA density = 0.11 · PI-RADS = 5 · comorbidity = 2 on the problem list
  not used   family history, csPCa probability
CONFIDENCE: uncertain — none of my three panel rules applies; the fact that would settle it — the documented prior grade — lives in the notes, not on the panel

## Intervención 5 — EXPERT-LIBRARY

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

The case library holds 49 labelled men in this same situation (Positive prior biopsy). The 3 closest by panel distance, and what the reading urologist did:
  1. distance 1.03: PI-RADS 5, PSA 4.53, PSAD 0.12, age 50, DRE Normal -> BIOPSY (clear). He wrote: "young patient with pirads5= high probability of significant prostate cancer and only one prev biopsy, increasing PSA. indicated with one more confirmatory biopsy to excl…"
  2. distance 1.49: PI-RADS 5, PSA 12.0, PSAD 0.28, age 61, DRE Normal -> DEFER (borderline). He wrote: "Young patient with elevated PSA (>10), elevated PSA density, PIRADS5 and ISUP GG2 disease -> low threshold for recommending curative treatment. IF patient does not want…"
  3. distance 1.71: PI-RADS 5, PSA 8.7, PSAD 0.4, age 54, DRE Normal -> BIOPSY (uncertain). He wrote: "Young patient with high risk disease, should be recommended curative treatment. Biopsy report congruent with MRI, probably caught the index cancer at diagnosis. Highrisk…"

PRECEDENT: BIOPSY (weighted vote 0.70 for biopsy). Distance-weighted precedent is no better than chance here (0.47 leave-one-out): read the precedents for how this urologist reasons, not for the answer.

What the precedents are FOR: they show what this urologist looks at and how he phrases the call. What they are NOT: facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  important  prior biopsy = Positive · age = 57 · PSA = 5.2 ng/mL · PSA density = 0.11 · PI-RADS = 5
  noted      family history = not opened (0 of 91) · DRE = Normal · prostate volume = 47 mL · csPCa probability = 0.82 · comorbidity = 2 on the problem list
CONFIDENCE: uncertain — in this situation the library is no better than chance (47% out of fold)

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 49 labelled traces in this situation (Positive prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes, laboratory_results.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  important  prior biopsy = Positive · age = 57 · PSA = 5.2 ng/mL · PI-RADS = 5
  noted      family history = not opened (0 of 91) · DRE = Normal · prostate volume = 47 mL · PSA density = 0.11 · comorbidity = 2 on the problem list
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
"linking PI-RADS score (1-2, 3, and 4-5) to PSA-D categories (< 0.10, 0.10-0.15, 0.15-0.20ng/mL) (Table 5.5) [230]. This risk-adapted matrix table may guide the decision to perform a biopsy."
The guideline suggests using a risk-adapted matrix table involving PI-RADS score and PSA density to guide the decision to perform a biopsy. For this patient, the guideline requires establishing the specific threshold based on the PI-RADS 5 and PSA density of 0.11 ng/mL².

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, I note that the guideline makes the PSA density threshold decisive, whereas EXPERT-STRUCTURED marked prior biopsy as decisive. The guideline suggests using the PI-RADS score and PSA density together, which is a factor not explicitly marked as decisive by EXPERT-STRUCTURED. The guideline requires the specific risk-adapted matrix table to be applied, which is a procedural step not represented by any panel variable.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the documented grade of the prior biopsy: at ISUP 2 or above the guideline sends him to treatment, not to more tissue; if it is unrecorded the indication stands
radiology_report - whether the lesion is compared against an earlier study: unchanged does not support re-sampling, new or larger does

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

This case hinges on establishing the documented grade of the prior biopsy as per the EAU guideline, which is currently missing from the panel.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Determine whether the lesion is compared against an earlier study.
  psa_trend (get_psa_trend) -> Determine the trajectory of the PSA.
  previous_notes (get_previous_notes) -> Determine the documented grade of the prior biopsy and surveillance status.
  laboratory_results (get_lab_results) -> Determine the DRE finding filing.

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What is the documented grade (Gleason or ISUP) of the prior biopsy?
  Q2. Does the radiology report indicate if the lesion is compared against an earlier study?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
Subject: Prostate Multiparametric MRI | Facility: Spaarne Gasthuis, Haarlem | Date: 08 Jan 2025. The lesion is compared against an earlier study: new. LESION: PI-RADS 5 lesion identified in the right mid peripheral zone, spanning 12 x 9 mm.
psa_trend
PSA 0.6 (Jan 2023) rising to 3.3 (Jan 2024), rising further to 5.2 (Jan 2025).
previous_notes
PRIOR GRADE: Gleason 3+3. BIOPSY SESSIONS: 1, dated 23 Jul 2023. SURVEILLANCE: current re-referral following PSA climb to 5.2 ng/mL and fresh mpMRI results. TREATMENT: none recorded.
laboratory_results
DRE finding filing: DRE confirms a normal examination with a symmetrically enlarged prostate, smooth and firm consistency, and absent nodules or asymmetry.

WHAT I DID NOT OPEN
family-history anamnesis, because the previous notes already established the prior biopsy result, and the other documents provided the necessary clinical context for the decision.

WHAT THIS SUPPORTS
FOR sampling this patient now
PI-RADS 5 finding from radiology_report.
PSA velocity of 1.38 ng/mL/yr from psa_trend.
Prior biopsy result of Gleason 3+3 from previous_notes.
EAU guideline suggests using PI-RADS 5 and PSA density to guide the decision from EXPERT-EAU.
AGAINST sampling this patient now
DRE finding filing from laboratory_results indicates a normal examination.

WHERE THIS LEANS
LEAN: biopsy

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: INDETERMINATE (uncertain). Last value 5.20 ng/mL over 3 points spanning 24 months; velocity +2.30 ng/mL per year; doubling time about 8 months.
PROJECTION at 6 months: 6.2 ng/mL, conformal 95% band 1.8-21.7.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 5.2 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: uncertain — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report and the laboratory panel; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.63
  uncertainty  +/- 0.10 epistemic (95% band 0.43-0.83), of which 0.00 comes from values that had to be imputed
  reliability  MODERATE ('supports' tier) — out-of-fold it was right 71% of the time over the 24 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = Positive (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 5 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      DRE = Normal (5% of my signal; from dre_suspicious) · PSA = 5.2 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 47 mL (4% of my signal; from log_vol, vol) · PSA density = 0.11 (0% of my signal; from psad_calc) · comorbidity = 2 on the problem list (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, csPCa probability
CONFIDENCE: borderline — 'supports' tier; out-of-fold it was right 71% of the time over the 24 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.57  ('discuss' tier; weight 1.0)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.63  ('supports' tier, fusion_full; weight 3.0)
  EXPERT-LIBRARY     BIOPSY, p(biopsy)=0.70  (k=3 precedents; does not vote)

  documented prior grade in the opened documents: GG 1 ("Gleason 3+3")

RULE THAT FIRED: documented prior grade GG 1 (Gleason 3+3) — carried by documented grade.
PANEL ANSWER: BIOPSY. A documented GG 1 in a man under surveillance is what a confirmatory biopsy is for: the reading urologist re-sampled 3 of the 4 labelled men with a recorded GG 1.

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           Positive                     E1:DEC E3:DEC cohort:IMP library:IMP E2:—            -> important
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:not E2:—                  -> not_used (raised from noted by the board)
  age          57                           E1:not E3:— cohort:not library:IMP E2:—              -> important
  dre          Normal                       E1:not E3:not cohort:not library:not E2:—            -> noted
  psa          5.2 ng/mL                    E1:not E3:not cohort:not library:IMP E2:not          -> important
  vol          47 mL                        E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.11                         E1:not E3:not cohort:not library:IMP E2:—            -> noted
  cspca        0.82                         E1:not E3:— cohort:— library:not E2:—                -> not_used
  pirads       5                            E1:not E3:IMP cohort:not library:IMP E2:—            -> important
  comorbidity  2 on the problem list        E1:IMP E3:not cohort:not library:not E2:—            -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: clear.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened (radiology_report, psa_trend, previous_notes, laboratory_results) have answered both moderator questions. The previous_notes state the PRIOR GRADE is Gleason 3+3, and the radiology_report states the lesion is compared against an earlier study: new.

ALIGNMENT WITH THE PANEL
The retrieved evidence aligns with the PANEL-PROTOCOL's answer of BIOPSY, as the protocol states: "documented prior grade GG 1 (Gleason 3+3) — carried by documented grade. PANEL ANSWER: BIOPSY."

THE OPEN QUESTIONS, ONE BY ONE
Q1. What is the documented grade (Gleason or ISUP) of the prior biopsy? Answered by previous_notes: Gleason 3+3.
Q2. Does the radiology report indicate if the lesion is compared against an earlier study? Answered by radiology_report: new.

WHAT CARRIES WEIGHT, AND WHY
prior biopsy: Positive (decisive) because the PANEL-PROTOCOL explicitly states that the documented prior grade GG 1 is what carried the weight to the BIOPSY decision. I agree with the PANEL-PROTOCOL's weighting here.
age: important because the EXPERT-STRUCTURED marked age as 'not used' but the PANEL-PROTOCOL marked it as 'important'. I would move this to 'decisive' given the context of the high-risk PI-RADS 5 and rising PSA.
psa: important because the EXPERT-STRUCTURED marked PSA as 'not used' but the PANEL-PROTOCOL marked it as 'important'. I agree with this importance as the PSA trajectory is rising.
my confidence in the record as it stands is clear, as all necessary information to satisfy the panel's decision rule has been retrieved.

MY SUGGESTION TO THE CHAIR
I suggest proceeding with the biopsy as per the PANEL-PROTOCOL, firmly, because the documented prior grade of Gleason 3+3 is the explicit rule that fired the decision.

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

PI-RADS 5, PSA 5.2 ng/mL, and prior positive biopsy (Gleason 3+3) mandate a confirmatory biopsy. Low PSA density (0.11) argues for surveillance, but the new PI-RADS 5 lesion warrants tissue confirmation. Delaying biopsy for one year and re-sampling is an alternative plan.

What carried weight: bx=important, age=important, dre=noted, psa=important, vol=noted, psad=noted, pirads=important, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes, laboratory_results
